Annotation Detail for CETP
Basic Information
Top
Pathway ID | Pathway Name |
---|
| Metabolism of lipids and lipoproteins |
Pathway ID | Pathway Name |
---|
500798 | LDL-mediated lipid transport |
500795 | Lipoprotein metabolism |
500797 | HDL-mediated lipid transport |
Desease ID | Desease Name |
---|
1740 | Alzheimer's disease |
1904 | Diabetes mellitus |
1934 | Cancer |
1951 | Overnutrition |
2203 | Nephrosis |
2236 | Cardiovascular disease |
Desease Name |
---|
hypercholesterolemia |
HDL cholesterol |
Biochemical measures |
cholesterol |
macroangiopathy |
cholesterol cholesterol, HDL cholesterol, LDL lipoprotein triglycerides |
cognitive function |
cardiovascular disease |
cholesterol, HDL |
Atrial Fibrillation |
cholesteryl ester transfer protein plasma lipid levels |
AGING |
atherosclerosis, coronary |
CARDIOVASCULAR |
Coronary Artery Disease |
myocardial infarct |
Diabetes Mellitus |
atherosclerosis, carotid |
plasma HDL cholesterol (HDL-C) levels |
plasma high-density lipoprotein cholesterol levels |
cardiovascular events in non-smokers |
PSYCH |
Lipid disorders |
cholesterol, HDL obesity |
cholesteryl ester transfer protein |
lipoprotein |
low CETP activity |
Cholesterol, HDL/blood* |
low high-density lipoprotein cholesterol concentration |
METABOLIC |
LDL cholesterol |
triglycerides |
obesity |
plasma HDL-C levels |
waist circumference and related phenotypes |
REPRODUCTION |
diabetes, type 2 |
cholesterol, HDL cholesterol, LDL |
carotid atherosclerosis |
high plasma CETP activity. |
exceptional longevity |
patent ductus arteriosus |
Desease Name |
---|
HDL cholesterol |
Biochemical measures |
Cholesterol |
Metabolic syndrome |
Waist circumference and related phenotypes |
Blood lipid traits |
Cardiovascular disease risk factors |
Triglycerides |
LDL cholesterol |
Age-related macular degeneration |
Desease Name |
---|
CETP deficiency |
Hyperalphalipoproteinemia |
High density lipoprotein cholesterol level QTL 10 |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C003585 |
22-hydroxycholesterol |
22-hydroxycholesterol results in increased expression of CETP mRNA | increases expression | 16142410
|
C003585 |
22-hydroxycholesterol |
[alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of CETP mRNA | affects cotreatment|increases expression | 16142410
|
C103303 |
alitretinoin |
[alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of CETP mRNA | affects cotreatment|increases expression | 16142410
|
C103303 |
alitretinoin |
[alitretinoin co-treated with TO-901317] results in increased expression of CETP mRNA | affects cotreatment|increases expression | 16142410
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of CETP mRNA | increases expression | 16142410
|
D008076 |
Cholesterol, HDL |
CETP gene polymorphism affects the abundance of Cholesterol, HDL | affects abundance | 16030523
|
D005632 |
Fructose |
Fructose results in increased expression of and results in increased activity of CETP protein | increases activity|increases expression | 11476189
|
D005632 |
Fructose |
Fructose results in increased expression of CETP mRNA | increases expression | 11476189
|
C473027 |
GW 3965 |
GW 3965 results in increased expression of CETP mRNA | increases expression | 19426978
|
D019829 |
Nevirapine |
Nevirapine results in increased expression of CETP protein | increases expression | 19667106
|
C025299 |
polyphenols |
polyphenols results in decreased activity of CETP protein | decreases activity | 16046716
|
C423915 |
TO-901317 |
[alitretinoin co-treated with TO-901317] results in increased expression of CETP mRNA | affects cotreatment|increases expression | 16142410
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of CETP mRNA | increases expression | 16142410 19426978
|
Pathway ID |
Pathway Name |
---|
REACT:22258 |
Metabolism of lipids and lipoproteins |
PharmGKB Accession:PA108
Releated gene ID |
Related gene Name |
PA108 | CETP |